C144H206N12O26S8 — CID 159720866
2-(1,3-benzothiazol-6-yl)-1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]ethanone;2-(1,3-benzoxazol-5-yl)-1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]ethanone;1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanone;1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-(2,3-dihydro-1H-inden-5-yl)ethanone;3-[2-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-oxoethyl]benzamide;3-[2-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-oxoethyl]-N-propan-2-ylbenzamide;1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-[4-(pyridin-4-ylmethyl)phenyl]ethanone (PubChem CID 159720866) has the molecular formula C144H206N12O26S8 and a molecular weight of 2777.83 g/mol. Its IUPAC name is 2-(1,3-benzothiazol-6-yl)-1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]ethanone;2-(1,3-benzoxazol-5-yl)-1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]ethanone;1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanone;1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-(2,3-dihydro-1H-inden-5-yl)ethanone;3-[2-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-oxoethyl]benzamide;3-[2-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-oxoethyl]-N-propan-2-ylbenzamide;1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-[4-(pyridin-4-ylmethyl)phenyl]ethanone.
| Compound Name | 2-(1,3-benzothiazol-6-yl)-1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]ethanone;2-(1,3-benzoxazol-5-yl)-1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]ethanone;1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanone;1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-(2,3-dihydro-1H-inden-5-yl)ethanone;3-[2-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-oxoethyl]benzamide;3-[2-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-oxoethyl]-N-propan-2-ylbenzamide;1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-[4-(pyridin-4-ylmethyl)phenyl]ethanone |
|---|---|
| PubChem CID | 159720866 |
| Molecular Formula | C144H206N12O26S8 |
| Molecular Weight | 2777.83 g/mol |
| Exact Mass | 2775.29 |
| IUPAC Name | 2-(1,3-benzothiazol-6-yl)-1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]ethanone;2-(1,3-benzoxazol-5-yl)-1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]ethanone;1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanone;1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-(2,3-dihydro-1H-inden-5-yl)ethanone;3-[2-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-oxoethyl]benzamide;3-[2-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-oxoethyl]-N-propan-2-ylbenzamide;1-[4-(tert-butylsulfonylmethyl)piperidin-1-yl]-2-[4-(pyridin-4-ylmethyl)phenyl]ethanone |
| SMILES | CC(C)(C)S(=O)(=O)CC1CCN(C(=O)Cc2ccc(Cc3ccncc3)cc2)CC1.CC(C)(C)S(=O)(=O)CC1CCN(C(=O)Cc2ccc3c(c2)CCC3)CC1.CC(C)(C)S(=O)(=O)CC1CCN(C(=O)Cc2ccc3c(c2)OCCO3)CC1.CC(C)(C)S(=O)(=O)CC1CCN(C(=O)Cc2ccc3ncsc3c2)CC1.CC(C)(C)S(=O)(=O)CC1CCN(C(=O)Cc2ccc3ocnc3c2)CC1.CC(C)(C)S(=O)(=O)CC1CCN(C(=O)Cc2cccc(C(N)=O)c2)CC1.CC(C)NC(=O)c1cccc(CC(=O)N2CCC(CS(=O)(=O)C(C)(C)C)CC2)c1 |
| InChI | InChI=1S/C24H32N2O3S.C22H34N2O4S.C21H31NO3S.C20H29NO5S.C19H26N2O4S.C19H28N2O4S.C19H26N2O3S2/c1-24(2,3)30(28,29)18-22-10-14-26(15-11-22)23(27)17-20-6-4-19(5-7-20)16-21-8-12-25-13-9-21;1-16(2)23-21(26)19-8-6-7-18(13-19)14-20(25)24-11-9-17(10-12-24)15-29(27,28)22(3,4)5;1-21(2,3)26(24,25)15-16-9-11-22(12-10-16)20(23)14-17-7-8-18-5-4-6-19(18)13-17;1-20(2,3)27(23,24)14-15-6-8-21(9-7-15)19(22)13-16-4-5-17-18(12-16)26-11-10-25-17;1-19(2,3)26(23,24)12-14-6-8-21(9-7-14)18(22)11-15-4-5-17-16(10-15)20-13-25-17;1-19(2,3)26(24,25)13-14-7-9-21(10-8-14)17(22)12-15-5-4-6-16(11-15)18(20)23;1-19(2,3)26(23,24)12-14-6-8-21(9-7-14)18(22)11-15-4-5-16-17(10-15)25-13-20-16/h4-9,12-13,22H,10-11,14-18H2,1-3H3;6-8,13,16-17H,9-12,14-15H2,1-5H3,(H,23,26);7-8,13,16H,4-6,9-12,14-15H2,1-3H3;4-5,12,15H,6-11,13-14H2,1-3H3;4-5,10,13-14H,6-9,11-12H2,1-3H3;4-6,11,14H,7-10,12-13H2,1-3H3,(H2,20,23);4-5,10,13-14H,6-9,11-12H2,1-3H3 |
| InChIKey | NAADLAOAZAFBBO-UHFFFAOYSA-N |
| XLogP | 20.00 |
| TPSA | 523.61 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 190 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2777.83 |
| LogP ≤ 5 | 20.00 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 30 |